US Patent 11498940 Neuroactive steroids, compositions, and uses thereof
Patent 11498940 was granted and assigned to SAGE Therapeutics on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Apr, 2023
Golden AI
Infobox
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114989400
Date of Patent
November 15, 2022
0Patent Application Number
168438220
Date Filed
April 8, 2020
0Patent Primary Examiner
Edits on 16 Nov, 2022
Golden AI
Edits made to:
Infobox (+18 properties)
US Patent 11498940 Neuroactive steroids, compositions, and uses thereof
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114989400
Date of Patent
November 15, 2022
0Patent Application Number
168438220
Date Filed
April 8, 2020
0Patent Primary Examiner
Find more entities like US Patent 11498940 Neuroactive steroids, compositions, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.